Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Market Tracker who wrote (601)	3/31/1999 9:47:00 PM
From: Jim	Respond to of 2515

A good friend who is a retired VP of JNJ told me to buy OSTE at 4$ about 3 yrs ago,I sold it 2 mo. back at 55$. [before split]He also told me to buy MEDI at 15,I sold it at 120 [before split].You now what he told me to buy 4 days before IMCL got fda ok phase111 YOU got!! I said thanks where is this one going,he said what price do you put on the cure for cancer!! I said I got you THANKS!!!! Four days later I called him and said IMCL looks good, he said wait till MAY,sould be 30 then 1yr 100. I believe him. GOOD LUCK SHORTS

To: Market Tracker who wrote (601)	3/31/1999 10:13:00 PM
From: Douglas Freeman	Read Replies (2) \| Respond to of 2515

Just in response to what Raven said, expecting the market to be rational is asking a little much. A lot much. If this stock stirs your ire, you'll have a ball in the internet section. I took a look at @home (an internet provider); $150 mil loss on $50 mil sales, and a market cap of $14 BILLION. Excuse me while I pick up the lower half of my face. What about AOL valued at almost $10,000 per customer? I'M FOR SALE!! Granted that's the internet, but curing 13 of 15 people of cancer should be allowed a little excitement too. As per no news for 12 months, in the meantime you get more people discovering the story & accumulating. "Word spreading". An absence of sellers too; news like we just had won't exactly send people rushing for the exits. Combine that with buyers of bulk (and today had bulk), and you're facing a stiff wind. At least you're doing it with more class than most. I took about 1/3 off the table at day end, so that much less to work through. I did it mostly out of concern for the overall market though. Ride on. ID

To: Market Tracker who wrote (601)	3/31/1999 11:44:00 PM
From: Jim Oravetz	Read Replies (1) \| Respond to of 2515

The link is broken, but try this: quicken.com Looks like the FBDIX fund has not had a particularily good first year investing in its area, biotech. The fund is still pretty small at only $83M. I wonder how much research they are getting on their targets. My guess is that they have as much of an idea about the company as any long term IMCL thread reader. I was looking thru the T/FIF thread trying to find some addition backgnd. There are several posts showing FBDIX's progress. Regarding IMCL, on the semi + side: Message 7770833 From Post 502 of T/FIF thread ...Four executives at ImClone bought a more modest 49,603 shares between Oct. 2 to Dec. 29. Director David Kies led the way, buying 31,603 shares. Mr. Elliot was particularly impressed by the consistency of Mr. Kies's purchases. Mr. Kies exercised options to buy stock and then bought shares on the open market when the stock price fell below the options price, Mr. Elliot said. "Some might say he was wrong, but his persistency impressed us -- it shows a sign of confidence," he added. on the semi - side: From Post 553 of the T/FIF, (Richard Harmon is a well respected contributor to several SI threads targeted at biotechs.) Message 7807333 Disclaimer: I do not own IMCL, but would like so soon (at lower prices of course!) Jim